Pataday and Ambien drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pataday (olopatadine hydrochloride) and Ambien (zolpidem tartrate). Common drug interactions include infection among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Pataday and Ambien. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.



On Jul, 20, 2026

81 people who take Pataday and Ambien together, and have interactions are studied.

Pataday and Ambien drug interactions.

What are the common drug interactions of Pataday and Ambien, by gender? *:

female:

  1. Infection
  2. Infusion site bruising
  3. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  4. Infusion site mass
  5. Osteonecrosis (death of bone)
  6. Pruritus (severe itching of the skin)
  7. Sinusitis (inflammation of sinus)
  8. Skin infection
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Urinary tract infection

male:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Migraine (headache)
  4. Therapeutic response unexpected
  5. Urinary tract infection
  6. Tendon rupture (tear of tendon)
  7. Acne (skin problems that cause pimples)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Chills (felling of cold)
  10. Chronic kidney disease

What are the common drug interactions of Pataday and Ambien, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Headache (pain in head)
  2. Vitamin d decreased

30-39:

  1. Abdominal pain upper
  2. Acne (skin problems that cause pimples)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hepatic enzyme increased
  7. Hepatitis (inflammation of the liver)
  8. Intentional self-injury
  9. Intervertebral disc protrusion (spinal disc protrusion)
  10. Neuralgia (pain in one or more nerves)

40-49:

  1. Bipolar disorder (mood disorder)
  2. Anxiety
  3. Contact lens intolerance (lens associated with irritation and redness of the eye)
  4. Drug ineffective
  5. Dry eye (lack of adequate tears)
  6. Eye inflammation
  7. Hypomania (a mild form of mania, marked by elation and hyperactivity)
  8. Lacrimation increased
  9. Memory impairment
  10. Pain

50-59:

  1. Urinary tract infection
  2. Tendon rupture (tear of tendon)
  3. Abdominal pain upper
  4. Arthralgia (joint pain)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Conjunctivitis (pink eye)
  7. Dyspnoea (difficult or laboured respiration)
  8. Hypersensitivity
  9. Infected cyst
  10. Intervertebral disc protrusion (spinal disc protrusion)

60+:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. Headache (pain in head)
  4. Migraine (headache)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)
  7. Urinary tract infection
  8. Chills (felling of cold)
  9. Dyspnoea (difficult or laboured respiration)
  10. Erythema (redness of the skin)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 25 people, 30.86%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 19 people, 23.46%
  3. Asthma: 11 people, 13.58%
  4. Pain: 10 people, 12.35%
  5. High Blood Pressure: 9 people, 11.11%
  6. Stress And Anxiety: 7 people, 8.64%
  7. Immunodeficiency Common Variable: 7 people, 8.64%
  8. High Blood Cholesterol: 7 people, 8.64%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 8.64%
  10. Depression: 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Pataday and Ambien?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pataday and Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and zolpidem tartrate (the active ingredients of Pataday and Ambien, respectively), and Pataday and Ambien (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: